Table 3.
Seropositivity of ANAs stratified by UDCA therapy.
| UDCA-naïve treatment n = 259 | UDCA treatment n = 131 | P | |
|---|---|---|---|
| anti-gp210 | 88/171 (34.0%) | 41/90 (31.3%) | 0.60 |
| anti-sp100 | 64/195 (24.7%) | 16/115 (12.2%) | 4.00 × 10−3 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.